StatLab
Todd Baldanzi has a solid work experience in finance and leadership roles. Todd currently serves as the Chief Financial Officer at StatLab since April 2021. Prior to this, Todd worked at McKesson for many years, holding various positions including Chief Financial Officer - US Pharma and Specialty Solutions, Chief Financial Officer - McKesson Canada, Chief Financial Officer - McKesson Medical Surgical, Chief Financial Officer - Retail Pharmacy Technology & Automation, and VP Finance - Moore Medical. Todd started their career as a Valuation Consultant at Arthur Andersen & Co. in 1996 and worked there until 2002.
Todd Baldanzi attended Colgate University from 1992 to 1996, where they obtained a Bachelor of Arts degree in International Relations and French. Afterwards, they pursued a Masters of Science in Professional Accounting at the University of Hartford from 1996 to 1997.
StatLab
StatLab is a leading specialty supplier exclusively focused on providing histology, cytology and immunohistochemistry consumable supplies to more than 3,000 anatomic pathology laboratories throughout the United States. Our foundation is rooted in customer service excellence and we recognize that product cost is but one aspect of the total value stream. Being able to offer consistent, reliable, and error-free service minimizes the total cost of doing business with StatLab and requires prioritization of service excellence throughout the organization. Continuous improvement efforts have resulted in a 98.1% same day fill rate, a 99.8% order accuracy rate, and an average “on-hold” wait time of less than 10 seconds when calling our customer service department. These are just some of the reasons we are the fastest growing histology consumable provider in the industry. Our purpose reflects the role we think we play: To enable our customers to provide cost-effective patient care. We take pride in the fact that we help our customers help patients by providing them with (1) high-quality products (consistent, reliable, and predictable), (2) delivered on time and (3) at a fair price. 1+2+3 = “cost-effective”.